Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

Overview

About this study

The investigator's global hypothesis is that women with Polycystic Ovary Syndrome (PCOS) can be separated into subtypes based on their response to metformin. The investigators propose here to use both targeted and non-targeted metabolomic approach to identify pathways associated with metformin's effect on insulin sensitivity and endothelial function. This pilot project will be the foundation for developing tailored therapeutic approaches to Polycystic Ovary Syndrome and identifying novel drug targets.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Body mass index (BMI) greater than or equal to 25
  • Polycystic Ovary Syndrome criteria of both oligomenorrhea (<9 menses per year) and androgen excess [clinical hirsutism (Ferriman-Gallway score >8 or severe acne) or elevated testosterone].
  • Taking no medications for the treatment of insulin resistance.

Exclusion Criteria:

  • Diagnosis of Cushing's syndrome
  • Untreated hypo/hyperthyroidism
  • Elevated prolactin
  • Congenital adrenal hyperplasia
  • Renal insufficiency (creatinine > 1.5)
  • Diabetes
  • Medications that can significantly affect endothelial function
  • Pregnancy
  • Breast Feeding
  • Taking oral contraceptives
  • Currently smoking

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Alice Chang, M.D., M.S.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions